GENE ONLINE|News &
Opinion
Blog

Heart Failure
AstraZeneca’s Forxiga Gets EU Nod To Treat Symptomatic Chronic Heart Failure
2023-02-08
Uncovering Racial Disparities in End-stage Heart Failure Therapies
2022-11-02
EC Approves New Indication for Teysuno to Address Hand-Foot Syndrome and Cardiotoxicity
2022-02-07
Eli Lilly and Boehringer Ingelheim’s Jardiance Shows Encouraging Phase 3 HFpEF Data
2021-07-07
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
Forxiga Gains Approval in China for Multiple Cardio-Related Diseases
2021-02-07
Merck and Bayer Enter the Congested Market of Heart Failure with Verquvo
2021-01-21
A Review of Neurological Symptoms in COVID-19 Patients
2020-05-18
ACE2: A Valuable Biomarker for COVID19 Susceptibility in Heart Patients
2020-05-16
R&D
Spotlight: The Many Facets of AstraZeneca’s Farxiga
2020-05-15
MyoKardia Announces Positive Topline Results for Targeted Cardiomyopathy Drug
2020-05-13
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top